Ge Healthcare Technologies Inc (GEHC) Gross Profit Margin starting from the first quarter 2026 to first quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Ge Healthcare Technologies Inc   (NASDAQ: GEHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Ge Healthcare Technologies Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GEHC Gross Profit Margin (Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2 		(Mar 31 2025)
Q1
Y / Y Revenue Change 7.17 %
Seq. Revenue Change -11.43 %
Revenue In Millions $4,260.00
Gross Profit Margin 46.41 %
Gross Profit Margin Total Ranking # 1842
Gross Profit In Millions $1,977.00
Y / Y Gross Profit Change -1.74 %
Seq. Gross Profit Change -12.56 %


Commenting First Quarter 2026 Gross Profit Margin
Ge Healthcare Technologies Inc experienced contraction in Gross Profit by -12.56 % to $4,260 millions and Revenue by -11.43 %, while Gross Profit Margin fell to 46.41 %, below company*s average Gross Profit Margin.


Observing first quarter 2026 results within Medical Laboratories industry 16 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1842, from total ranking in the previous quarter at 1963.
Learn about Gross Margin
GEHC's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 17
Healthcare Sector # 330
Overall # 1827

Gross Profit Margin Statistics
High Average Low
50.62 % 46.78 % 38.64 %
(Mar 31 2025)   (Mar 31 2022)


GEHC Gross Income Trends • More of GEHC's Profitabilty Ratios • GEHC Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
GEHC's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
GEHC's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for GEHC's Competitors
Gross Profit Margin Profit Margin for Ge Healthcare Technologies Inc 's Suppliers
Gross Profit Margin Profit Margin for GEHC's Customers

You may also want to know
GEHC's Annual Growth Rates GEHC's Profitability Ratios GEHC's Asset Turnover Ratio GEHC's Dividend Growth
GEHC's Roe GEHC's Valuation Ratios GEHC's Financial Strength Ratios GEHC's Gross Profit Growth
GEHC's Roa GEHC's Inventory Turnover Ratio GEHC's Growth Rates GEHC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Medical Laboratories Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Biodesix Inc   99.92 %$ 25.535  Millions$ 25.555  Millions
Omniab Inc   99.90 %$ 14.412  Millions$ 14.427  Millions
Lightwave Logic Inc   95.42 %$ 0.028  Millions$ 0.029  Millions
Incyte Corporation  91.79 %$ 1,168.153  Millions$ 1,272.676  Millions
Caredx Inc   85.47 %$ 100.603  Millions$ 117.700  Millions
Maxcyte inc   83.74 %$ 8.082  Millions$ 9.651  Millions
Castle Biosciences Inc   75.46 %$ 63.146  Millions$ 83.679  Millions
Veracyte Inc   75.40 %$ 101.159  Millions$ 134.159  Millions
Billiontoone Inc   73.17 %$ 79.096  Millions$ 108.096  Millions
Butterfly Network Inc   69.56 %$ 18.285  Millions$ 26.285  Millions
Guardant Health Inc   65.22 %$ 196.746  Millions$ 301.665  Millions
Natera Inc   64.80 %$ 451.441  Millions$ 696.644  Millions
Inotiv Inc   62.58 %$ 73.627  Millions$ 117.652  Millions
Nrc Health  60.79 %$ 21.157  Millions$ 34.803  Millions
Exagen Inc   59.31 %$ 10.205  Millions$ 17.205  Millions
Grail Inc   47.91 %$ 19.541  Millions$ 40.785  Millions
Ge Healthcare Technologies Inc   46.41 %$ 1,977.000  Millions$ 4,260.000  Millions
Ispecimen inc   45.89 %$ 0.072  Millions$ 0.156  Millions
Charles River Laboratories International inc   38.85 %$ 386.923  Millions$ 995.830  Millions
Iqvia Holdings Inc   32.64 %$ 1,355.000  Millions$ 4,151.000  Millions
Quest Diagnostics Inc  32.54 %$ 942.000  Millions$ 2,895.000  Millions
Fulgent Genetics Inc   30.49 %$ 21.490  Millions$ 70.490  Millions
Labcorp Holdings Inc   28.66 %$ 1,013.800  Millions$ 3,537.600  Millions
Medpace Holdings Inc   27.78 %$ 196.326  Millions$ 706.604  Millions
American Shared Hospital Services  20.48 %$ 1.288  Millions$ 6.288  Millions
Fortrea Holdings Inc   19.42 %$ 123.600  Millions$ 636.500  Millions
Aclarion Inc   17.74 %$ 0.004  Millions$ 0.021  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.